Announcements Trials
Browse Landscape

Phase

Phase 1 4Phase 3 3Phase NA 2Phase EARLY_PHASE1 1Phase 2 1

Status

Completed 2Not yet recruiting 1

Sponsor Class

OTHER_GOV 1OTHER 1INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 1Dermatologic 1Breast 1

Conditions

Melanoma 1Lymphatic Metastasis 1Lung Neoplasms 1Breast Neoplasms 1

Interventions

Cisplatin 726Carboplatin 609Paclitaxel 579Cyclophosphamide 516Radiotherapy 511Docetaxel 477Fluorouracil 454Gemcitabine 438Doxorubicin 383Capecitabine 362Dexamethasone 328Oxaliplatin 289pembrolizumab 283Leucovorin 283Bevacizumab 275Etoposide 272Vincristine 270Rituximab 246Prednisone 223Pemetrexed 217Cytarabine 205Drug Therapy 194Trastuzumab 176Irinotecan 174Methotrexate 171Lenalidomide 137Nivolumab 136Filgrastim 135Epirubicin 129Tamoxifen 128

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 3 × Technetium × Clear all
NCT07552597 2026-04-27

MagMen-II

Vastra Gotaland Region

Phase 3 Not yet recruiting
254 enrolled
Dermatologic

Melanoma

NCT04233476 2024-07-01

TRIIL

RDO Pharm.

Phase 3 Completed
409 enrolled
Thoracic

Lung Neoplasms, Lymphatic Metastasis

NCT02279108 2018-04-09

FLUOTECH

Centre Hospitalier Universitaire de Saint Etienne

Phase 3 Completed
99 enrolled 15 charts
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡